Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism DOT1L inhibitors(DOT1 like histone lysine methyltransferase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC32H45N7O2 |
InChIKeyRKRUMZCAPLOLQM-JOMNVXSOSA-N |
CAS Registry2766698-38-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hematologic Neoplasms | Preclinical | CZ | 14 Apr 2022 |